PFE•benzinga•
Pfizer's Covid Windfall Shrinks, Expands Cost-Cutting Efforts
Summary
Pfizer beats Q1 EPS estimates, maintains 2025 guidance, and targets $5.7 billion in cost savings through automation and R&D streamlining.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 29, 2025 by benzinga